MC1817A1 - Derives de tetrahydronaphtalene - Google Patents

Derives de tetrahydronaphtalene

Info

Publication number
MC1817A1
MC1817A1 MC871883A MC1883A MC1817A1 MC 1817 A1 MC1817 A1 MC 1817A1 MC 871883 A MC871883 A MC 871883A MC 1883 A MC1883 A MC 1883A MC 1817 A1 MC1817 A1 MC 1817A1
Authority
MC
Monaco
Prior art keywords
compound
compounds
general formula
tetrahydro
prepared
Prior art date
Application number
MC871883A
Other languages
English (en)
French (fr)
Inventor
Klaus Michael
Loeliger Peter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1817A1 publication Critical patent/MC1817A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
MC871883A 1986-05-13 1987-05-11 Derives de tetrahydronaphtalene MC1817A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1938/86A CH668962A5 (de) 1986-05-13 1986-05-13 Tetrahydronaphthyl-propenyl-phenole.
CH74287 1987-02-26

Publications (1)

Publication Number Publication Date
MC1817A1 true MC1817A1 (fr) 1988-03-18

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871883A MC1817A1 (fr) 1986-05-13 1987-05-11 Derives de tetrahydronaphtalene

Country Status (20)

Country Link
CN (1) CN87103524A (de)
AU (1) AU7277987A (de)
BE (1) BE1001668A5 (de)
DE (1) DE3715809A1 (de)
DK (1) DK232087A (de)
ES (1) ES2005572A6 (de)
FI (1) FI872027L (de)
FR (1) FR2598706B1 (de)
GB (1) GB2190378B (de)
HU (1) HU198002B (de)
IL (1) IL82448A0 (de)
IT (1) IT1203954B (de)
LU (1) LU86866A1 (de)
MC (1) MC1817A1 (de)
NL (1) NL8701101A (de)
NO (1) NO871961L (de)
NZ (1) NZ220215A (de)
PT (1) PT84860B (de)
SE (1) SE8701933L (de)
ZW (1) ZW6587A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5475022A (en) 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5534641A (en) * 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) * 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6942980B1 (en) 1995-09-01 2005-09-13 Allergan, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
CA1162200A (en) * 1981-02-13 1984-02-14 Michael Klaus Process for the manufacture of indanyl (or tetrahydronaphthyl)propenyl phenyl derivatives
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
EP0084667B1 (de) * 1982-01-23 1985-09-18 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
NZ220215A (en) 1990-06-26
PT84860B (pt) 1990-02-08
DK232087A (da) 1987-11-14
IT1203954B (it) 1989-02-23
FR2598706A1 (fr) 1987-11-20
NO871961L (no) 1987-11-16
GB2190378A (en) 1987-11-18
GB2190378B (en) 1990-11-14
HU198002B (en) 1989-07-28
PT84860A (en) 1987-06-01
IT8720232A0 (it) 1987-04-23
GB8711205D0 (en) 1987-06-17
BE1001668A5 (fr) 1990-02-06
CN87103524A (zh) 1987-12-02
ES2005572A6 (es) 1989-03-16
AU7277987A (en) 1987-11-19
FI872027A0 (fi) 1987-05-07
FI872027A7 (fi) 1987-11-14
DE3715809A1 (de) 1987-11-19
NL8701101A (nl) 1987-12-01
FI872027L (fi) 1987-11-14
ZW6587A1 (en) 1987-12-02
LU86866A1 (de) 1988-06-13
DK232087D0 (da) 1987-05-06
HUT43806A (en) 1987-12-28
FR2598706B1 (fr) 1990-07-06
NO871961D0 (no) 1987-05-12
IL82448A0 (en) 1987-11-30
SE8701933L (sv) 1987-11-14
SE8701933D0 (sv) 1987-05-11

Similar Documents

Publication Publication Date Title
MC1817A1 (fr) Derives de tetrahydronaphtalene
BE1000660A5 (fr) Derives de tetrahydronaphtalene et d'indane.
EP0161156B1 (de) 4-Vinylbenzoesäure-Derivate, ihre Herstellung und Verwendung als Arzneimittel und Ligande
MC1990A1 (fr) Nouveaux derives du benzocycloheptene
MC1596A1 (fr) Composes utiles pour le traitement des etats allergiques
HU203076B (en) Process for producing arylhydroxamic acid derivatives and pharmaceutical compositions comprising such compounds, as well as composition regulating plant growth and delaying fading of cut flowers
MC1512A1 (fr) Nouveaux derives d'acide phenoxyalkylcarboxylique
US4309407A (en) Alkenyl-substituted thienylalkanecarboxylic acids and derivatives thereof
US4325974A (en) β, γ-Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
US4686235A (en) Substituted cinnamyl-2,3-dihydrobenzofuran and analogs useful as anti-inflammatory agents
IE52630B1 (en) Substituted biphenyl compounds
JPH0449533B2 (de)
US4778818A (en) Substituted 2-(heteroaryl-2-propenyl)phenols useful as anti-inflammatory agents
FR2534582A1 (fr) Nouveaux derives de benzofuranne et de benzothiophene, utiles comme agents anti-hyperuricemie et anti-hypertension, et leur procede de fabrication
EP0051514B1 (de) Cinnamoyl-Zimtsäure-Derivat, seine Herstellung und seine therapeutische Anwendung
MC1175A1 (fr) Derives polyeniques
EP0017578B1 (de) 5-(2-Hydroxy-3-thiopropoxy)-chromon-2-carbonsäuren, ihre Salze und Ester, Verfahren zur Herstellung und Arzneimittel
EP0337885B1 (de) Trienische Derivate mit chromenischer Struktur, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
US5464865A (en) 4-aryl- and 4-arylthio-5-hydroxy-2(5H)-furanones as inhibitors of phospholipase A2
BE897118A (fr) Composes polyethyleniques
US4405810A (en) 7-Aryl-hept-5-ynoic acids and derivatives thereof
FR2556592A1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
JPS6248639A (ja) 薬剤化合物
CS265240B2 (en) Process for preparing tetrahydrotetramethylnaphthylpropenylphenoles
EP0037777A1 (de) Verfahren zur Herstellung von als Heilmittel verwendbaren Cycloalcoyl-propanol-aminen

Legal Events

Date Code Title Description
YP Annual fee paid
YP Annual fee paid